Background Image
Table of Contents Table of Contents
Previous Page  47 / 74 Next Page
Information
Show Menu
Previous Page 47 / 74 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 5, September/October 2017

AFRICA

321

0.001) (Table 4, Fig. 1). RDW was positively correlated with

Gensini score, obstructive CAD and triple-vessel disease (

r

=

0.468,

r

=

0.409 and

r

=

0.332, respectively and

p

<

0.001 for all).

Discussion

This study showed an association between RDW and CAD in

diabetic patients. RDW values were found to be higher in the

diabetic CAD population and higher RDW values were related

to more extensive and complex coronary lesions.

RDW is a marker of the variation in size of red blood cells

circulating in the body, which reflects the value of anisocytosis.

1

It is routinely reported during automated complete blood

counts. An elevation in RDW values may be seen in patients

with ineffective erythropoiesis (iron, vitamin B

12

or folic acid

deficiency and various haemoglobinopathies), recent blood

transfusions and haemolysis.

15

In daily practice it is commonly

used to narrow the differential diagnosis of anaemia.

2

The growing attention given to the relationship between RDW

and cardiovascular events was first spurred on by the report

from Felker

et al

., which concluded that there was a strong and

independent association between RDW and the risk of adverse

outcomes in heart failure patients.

16

Subsequently, Tonelli

et al

.

predicted an independent relationship between RDW and the

risk of cardiovascular death in patients with CAD.

3,16

Following

the direction of these studies, researchers reported that higher

RDW values were also associated with a worse prognosis in

peripheral artery disease and even in the unselected population.

5,6

Several explanations could be postulated in order to explain

the underlying mechanisms that may contribute to a worse

prognosis among patients with cardiovascular disease. However

the reason for the poor prognosis remains unclear.

It has not been determined yet whether RDW is a marker of

the severity of various disorders or if there is direct link between

anisocytosis and poor prognosis in patients with CAD. Factors

Table 2. Baseline characteristics and laboratory

findings of low and high RDW groups

Variables

Low RDW

(

13.25)

(

n

=

46)

High RDW

(

>

13.25)

(

n

=

78)

p-

value

Age (years)

56.7

±

8.0

58.2

±

9.5

0.381

Gender (male)

27 (59)

41 (53)

0.318

Hypertension

38 (83)

66 (85)

0.478

Dyslipidaemia

29 (63)

48 (61)

0.511

Smoking

5 (11)

19 (24)

0.052

Aspirin

33 (72)

60 (77)

0.331

Clopidogrel

11 (24)

12 (15)

0.173

RAS blockers

32 (70)

61 (78)

0.195

β

-blockers

28 (61)

38 (49)

0.130

Calcium channel blockers

9 (20)

14 (18)

0.501

Statins

13 (28)

30 (39)

0.169

Body mass index (kg/m

2

)

28.8

±

4.5

28.0

±

4.5

0.363

Systolic blood pressure (mmHg)

131

±

13

133

±

15

0.328

Diastolic blood pressure (mmHg)

78

±

8

79

±

8

0.196

Glucose (mg/dl)

163

±

77

181

±

79

0.207

[mmol/l]

[9.05

±

4.27]

[10.05

±

4.38]

Creatinine (mg/dl)

0.63

±

0.17

0.76

±

0.31 0.008

[μmol/l]

[55.69

±

15.03]

[67.18

±

27.40]

Uric acid (mg/dl)

4.6

±

1.5

5.1

±

1.7

0.213

hs-CRP (mg/l)

4.11

±

1.88

7.12

±

5.58 0.043

Total cholesterol (mg/dl)

195

±

44

202

±

52

0.481

[mmol/l]

[5.05

±

1.14]

[5.23

±

1.09]

Triglycerides (mg/dl)

197

±

173

188

±

114 0.736

[mmol/l]

[2.23

±

1.95]

[2.12

±

1.29]

LDL cholesterol (mg/dl)

114

±

33

127

±

48

0.088

[mmol/l]

[2.95

±

0.85]

[3.29

±

1.24]

HDL cholesterol (mg/dl)

46

±

15

44

±

12

0.461

[mmol/l]

[1.19

±

0.39]

[1.14

±

0.31]

WBC (10

3

cells/µl)

7.1

±

1.9

7.3

±

2.2

0.516

Haemoglobin (g/dl)

13.3

±

1.5

13.0

±

1.6

0.454

RDW (%)

12.9

±

0.7

14.3

±

1.4

0.001

MPV (fl)

8.35

±

1.13

8.72

±

0.93 0.049

Neutrophil/lymphocyte ratio (%)

1.92

±

0.07

2.89

±

2.33 0.009

RDW: red cell distribution width, RAS: renin–angiotensin system, hs-CRP:

high-sensitivity C-reactive protein, LDL: low-density lipoprotein, HDL: high-

density lipoprotein, WBC: white blood cells, MPV: mean platelet volume.

Data are shown as

n

(%) or mean

±

SD

Table 3. Severity of coronary artery disease between

low and high RDW groups

Variables

Low RDW (

13.25)

(

n

=

46)

High RDW (

>

13.25)

(

n

=

78)

p-

value

Gensini score

Total

11 [4–31]

43 [16–73]

<

0.001

LAD

5 [3–12]

18 [5-30]

0.001

Cx

3 [1–5]

7 [3–19]

<

0.001

RCA

2 [1–3]

7 [2–18]

<

0.001

Obstructive CAD

23 (50)

63 (81)

0.001

Triple-vessel disease

2 (4)

26 (33)

<

0.001

RDW: red cell distribution width, LAD: left anterior descending coronary

artery, Cx: circumflex coronary artery, RCA: right coronary artery, CAD: coro-

nary artery disease. Data are shown as

n

(%) or median [interquartile range].

Table 4. Diagnostic accuracy of red cell distribution

width for coronary artery disease

Variable Cut-off value AUC 95% CI of AUC Sensitivity Specificity

p-

value

a

RDW (%)

>

13.25 0.742 0.679–0.806 0.629

0.771

<

0.001

AUC: area under the receiver operating characteristic curve, CI: confidence

interval, RDW: red cell distribution width.

a

Significance level of AUC.

1 – Specificity

0.0

0.2

0.4

0.6

0.8

1.0

Sensitivity

1.0

0.8

0.6

0.4

0.2

0.0

– : RDW (%)

Fig. 1.

Receiver operating characteristic curve showing the

relationship between sensitivity and false positivity at

various cut-off points for red cell distribution width to

predict coronary artery disease.